Amicogen, Inc. (KOSDAQ:092040)
3,615.00
+5.00 (0.14%)
Jun 19, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Raw Drug Substance | 120.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Raw Drug Substance Growth | 12.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical | 55.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical Growth | 13.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -15.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 33.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Disease Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Disease Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Overseas | 132.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 470.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 27.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -77.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|